Sirolimus-Eluting Coronary Stents

The VA Healthcare Network Upstate New York (VISN 2), which includes medical centers in Albany, Bath, Canandaigua, Syracuse, and Buffalo, is initiating contract negotiations with Johnson & Johnson Health Care Systems, Inc. for the procurement of Sirolimus-Eluting Coronary Stents. The government intends to use a sole-source procurement process under FAR 6.302, negotiating exclusively with Johnson & Johnson. However, other interested parties are invited to submit written notifications of interest along with relevant descriptive literature and specifications to the Contracting Officer at the Stratton VA Medical Center in Albany, NY. This information will be used solely to determine whether a competitive procurement is warranted, with the government holding sole discretion on whether to proceed competitively. The contract solicitation, identified by the number VA-SNOTE-030515-001 and posted on May 15, 2003, falls under the Department of Veterans Affairs Network Contract Office 02 based in Albany, NY. While specific details such as NAICS codes or set-aside types were not defined, the solicitation pertains specifically to Sirolimus-Eluting Coronary Stents, a specialized medical device. Interested parties are encouraged to submit proposals or expressions of interest via fax to facilitate the government’s assessment of market capability, although the decision not to open the procurement to competition lies entirely with the government.